After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that N/A.
Stocks Info
Globus Medical Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Globus Medical Inc is $8.29B. A total of 4.01 million shares were traded on the day, compared to an average of 1.54M shares.
In the most recent transaction, RHOADS ANN D sold 7,500 shares of GMED for 78.68 per share on Feb 28 ’25. After the transaction, the Director now owns 35,384 company shares. In a previous transaction on Feb 28 ’25, RHOADS ANN D bought 7,500 shares at 78.67 per share.
Among the insiders who sold shares, Pfeil Keith W disposed of 14,167 shares on Jan 10 ’25 at a per-share price of $88.29. This resulted in the COO, CFO holding 0 shares of GMED after the transaction. In another insider transaction, Pfeil Keith W bought 14,167 shares at $88.29 per share on Jan 10 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, GMED has a high of $94.93 and a low of $54.48.
As of this writing, GMED has an earnings estimate of $0.78 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $0.89 per share and a lower estimate of $0.72.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GMED’s latest balance sheet shows that the firm has $443.45M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $30.20, while its Total Shareholder’s Equity was $1.74B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GMED is Buy with a score of 4.27.
